Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brainsway Deep TMS System for Treatment of Major Depressive Disorder (MDD) Using Intermittent Theta Burst Stimulation (iTBS) Protocol

NCT04679753 is registered in ClinicalTrials.gov with Brainsway as lead sponsor.

NCT NCT04679753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04679753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brainsway Deep TMS System for Treatment of Major Depressive Disorder (MDD) Using Intermittent Theta Burst Stimulation (iTBS) Protocol
Lead sponsor
Brainsway
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2019
Completion date
July 1, 2020
Enrollment
177 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder